Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Ethical review of interpretive research: problems and solutions.

Jacobson N, Gewurtz R, Haydon E.

IRB. 2007 Sep-Oct;29(5):1-8. No abstract available.

PMID:
17969777
2.

Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users.

Fischer B, Rehm J, Patra J, Kalousek K, Haydon E, Tyndall M, El-Guebaly N.

Addiction. 2006 Dec;101(12):1760-70.

PMID:
17156175
3.

Community-based interventions and alcohol, tobacco and other drugs: foci, outcomes and implications.

Giesbrecht N, Haydon E.

Drug Alcohol Rev. 2006 Nov;25(6):633-46. Review.

PMID:
17132579
4.

Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market.

Haydon E, Rehm J, Fischer B, Monga N, Adlaf E.

Can J Public Health. 2005 Nov-Dec;96(6):459-61.

PMID:
16350874
5.

[Willing to undergo hepatitis C treatment in a sample of injection drug users in Toronto, Canada].

Fischer B, Vasdev S, Haydon E, Baliunas D, Rehm J.

Presse Med. 2005 Oct 8;34(17):1209-12. French.

6.

Feasibility and outcome of HCV treatment in a Canadian federal prison population.

Farley J, Vasdev S, Fischer B, Haydon E, Rehm J, Farley TA.

Am J Public Health. 2005 Oct;95(10):1737-9. Epub 2005 Aug 30.

7.

Hepatic epithelioid haemangioendothelioma.

Haydon E, Haydon G, Bramhall S, Mayer AD, Niel D.

J R Soc Med. 2005 Aug;98(8):364-5. Review. No abstract available.

8.

Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'.

Haydon E, Fischer B.

Can J Public Health. 2005 May-Jun;96(3):185-8.

PMID:
15913081
9.

Determinants of overdose incidents among illicit opioid users in 5 Canadian cities.

Fischer B, Brissette S, Brochu S, Bruneau J, el-Guebaly N, Noël L, Rehm J, Tyndall M, Wild C, Mun P, Haydon E, Baliunas D.

CMAJ. 2004 Aug 3;171(3):235-9.

10.

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Fischer B, Haydon E, Rehm J, Krajden M, Reimer J.

J Urban Health. 2004 Sep;81(3):428-47.

11.

The importance of environmental modifiers of the relationship between substance use and harm.

Rehn J, Fischer B, Graham K, Haydon E, Mann RE, Room R.

Addiction. 2004 Jun;99(6):663-6. No abstract available.

PMID:
15139864
12.

Screening for antisocial personality disorder in drug users--a qualitative exploratory study on feasibility.

Fischer B, Haydon E, Kim G, Rehm J, El-Guebaly N.

Int J Methods Psychiatr Res. 2003;12(3):151-6.

PMID:
12953142

Supplemental Content

Loading ...
Support Center